


































Using Science to Save Lives:  
CDC AND THE FIGHT  
AGAINST GLOBAL HIV/AIDS 
 






Landmark scientific advancements have brought the 
world to a tipping point in the fight against HIV/AIDS – a point 
where the potential for achieving an AIDS-free generation is 
possible. We now have the tools to dramatically drive down 
the rate of new HIV infections, allowing the United States and 
the global health community to take concrete steps towards 
ending the HIV epidemic.  
 
Under the leadership of Dr. Eric Goosby, U.S. Global AIDS 
Coordinator for the President’s Emergency Plan for AIDS 
Relief (PEPFAR), we are making incredible progress by  
leveraging science, innovation, and evidence-based strategies 
to save millions of lives in countries hardest hit by this 
devastating disease. 
 
In the past two years there has been a 60% increase in the 
number of people accessing lifesaving treatment. Previously, 
this level of progress took a decade to achieve. Similar strides 
have been made in PEPFAR’s scale up of treatment to prevent 
mother-to-child transmission.  
 
The gains we’ve made are impressive but our work is not 
done. To prevent losing ground, we must continue to 
aggressively scale-up prevention interventions proven to halt 
the spread of HIV. A historic opportunity is before us – the 
containment of the HIV/AIDS epidemic.  
 
As PEPFAR moves forward to achieve an AIDS-free 
generation, CDC remains resolute in our commitment to this 
fight and halting the devastation this disease has brought to 
families, communities, and nations around the world.  
 
Thomas R. Frieden, MD, MPH 
Director, Centers for Disease Control and Prevention 






“An AIDS-free generation … is within our reach.” 














“The goal of an AIDS-free generation may be ambitious, but it is possible with 
the knowledge and interventions we have right now.  And that is something 
we’ve never been able to say without qualification before.  Imagine what the 
world will look like when we succeed.”  




And the commitment continues… 
 
 
“Today, astonishingly, we are standing on the edge of the 
potential of an AIDS-free generation … because we believe 
that relieving preventable suffering doesn’t need a 
justification. And I think that’s part of our values.”  
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Section 1:  
TURNING THE TIDE ON THE  


















A MODERN-DAY PLAGUE, UNCHECKED 
In 2001, HIV/AIDS threatened the foundations of societies and created such instability that the United Nations Security 
Council identified HIV as a global security threat. By 2005, the epidemic had quickly spread around the world, taking the 
lives of 2.3 million men, women, and children in that year alone (see figure 1 below). 
 
This modern-day plague hid within populations and individuals without symptomatic detection for years, which resulted 
in it rapidly spreading and overwhelming the ability of many countries to respond, bringing despair and economic 
instability. By 2005, four people died from HIV/AIDS every minute. 
 






















Source: UNAIDS Report on the Global AIDS Epidemic, 2012 
 




TODAY, A VERY DIFFERENT PICTURE  
The United States and a world community united in the 
fight against HIV/AIDS have made unprecedented 
progress, changing the face of the epidemic and saving 











In 2012, UNAIDS reported historic gains towards ending 
AIDS, including dramatic declines in new HIV infections 
and HIV-related deaths (see box at right).  
Figure 2 below shows the declining trajectory of new 
HIV infections as antiretroviral treatment increased. 
 
The acceleration of progress over the last few years is also reflected in terms of longer life span (life-years gained) due to 
antiretroviral treatment (see figure 3).  
 
Figure 2      Figure 3    













50% reduction in new HIV infections 
between 2001 and 2011in 25 countries  
 
43% decline in new HIV infections in 
children from 2003 to 2011, with  
over half of that decline occurring 
within the last two years 
 
50% or greater drop in HIV/AIDS-
related deaths between 2005 and  
2011 in 14 countries, with another  
29 countries achieving a reduction  
of 25-49% 
 
25% decline in TB-related deaths 
worldwide and 28% decline in  
sub-Saharan Africa between  
2004 and 2011 
 
Source: UNAIDS World AIDS Day Report, 2012 
Progress in Fighting the Epidemic 
 Source: UNAIDS Report on the Global AIDS Epidemic, 2012 Source: UNAIDS, Together We Will End AIDS, 2012 
 








A Leader Emerges 
 
THE UNITED STATES  
The United States has played a lead role in the fight against HIV/AIDS with the launch of the U.S. 
President's Emergency Plan for AIDS Relief (PEPFAR) in 2003. Congress appropriated $15 billion for 
the first five years and reauthorized PEPFAR in 2008 for $48 billion with strong bipartisan support. 
 
Under the leadership of the Office of the U.S. Global AIDS Coordinator in the Department of State, 
PEPFAR targets resource-constrained countries hardest hit by the epidemic and increases its impact by 






PEPFAR Implementing Agencies 
 
Department of Commerce (DoC) 
Department of Defense (DoD) 
Department of Health and Human Services (DHHS)  
Department of Labor (DoL) 
Peace Corps 







Other Key Players 
 
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS, AND MALARIA  
Championed by the United States, the Global Fund was established in 2002 and has since invested billions of 
dollars from donor countries to assist countries hardest hit by these diseases but lack the resources to 
combat them. To date, $22.9 billion has been donated to 151 countries.
Ambassador Eric Goosby,  








INTERNATIONAL AND U.S. PARTNERS 
Health is an international priority in which U.S. expertise, leadership, and experience 
can guide effective collaborative action. “Health is the issue that aligns the interests of 
countries around the world. If we can limit the spread of pandemics all people benefit,” 
said Kathleen Sebelius, Secretary of Health and Human Services, at the release of the 
HHS Global Health Strategy (January 2012). 
 
Many partners and stakeholders have made and continue to make essential contributions  
to the global HIV response. They include, but are not limited to, the following:  
  
• World Health Organization (WHO) 
• Joint United Nations Programme on HIV/AIDS (UNAIDS) 
• The United Children’s Fund (UNICEF) 
• World Bank 
• Ministries of Health 
• Faith-Based Organizations and Foundations   
• Private Sector Partners 









CDC’s Role in PEPFAR  
 
SCIENCE, INNOVATION, AND COLLABORATION 
On the front lines since the start of the epidemic, CDC has been fighting HIV/AIDS for 
more than 30 years, and has played a critical role in PEPFAR since its inception. 
Leveraging the agency’s public health expertise, applying the latest science, and working 
through collaborations has led to accelerated progress, program innovation, and 
increased health impact.  
 
AN EXPANDED ROLE 
After the launch of PEPFAR, U.S. Congressional leaders recognized the importance  
of a public health science-based approach to ensure program effectiveness, and 
expanded CDC’s role in the Tom Lantos and Henry J. Hyde Act of 2008  
reauthorizing PEPFAR (see box below). 
 
2008 PEPFAR legislation expands CDC’s role in: 
 
• Evidence-based prevention interventions 
• Program monitoring and evaluation 
• Impact evaluation operations research  
 
• Laboratory and workforce capacity 
• Health systems strengthening 






Secretary of Health 
and Human Services 
 










Achieving an AIDS-Free Generation 
 
SCIENCE GUIDES STRATEGY 
Scientific findings have shown three interventions to be pivotal for dramatically 
driving down the rate of new HIV infections and, if brought to scale, could pave 
the way for achieving an AIDS-free generation (see box at right).  
These interventions include:  
 
 
Antiretroviral Treatment (ART)  
 
Research findings demonstrate that ART is highly effective in reducing the 
risk of HIV transmission by 96%. (N Eng J Med. 2011; 365: 493-505) 
 
Preventing Mother-To-Child HIV Transmission 
 
With antiretroviral drugs, an HIV-positive mother’s risk of transmitting  
the virus to her child is reduced to less than 5%. [WHO, Antiretroviral Drugs for 
Treating Pregnant Women and Preventing HIV Infection in Infants (2010)] 
 
Voluntary Medical Male Circumcision 
 
This one-time intervention reduces the risk that men will acquire the virus 
from women by more than 60%, which also benefits women by lowering 
the rate of infection among men. (PloS Med. 2005; 2e298 and Lancet. 2007; 




The PEPFAR Blueprint: Creating an AIDS-Free Generation 
The Obama Administration unveiled the Blueprint on November 29, 2012.  
The Blueprint provides a roadmap for what the United States will do  









• Virtually no children are born 
infected with the HIV virus 
• As these children become 
teens and adults, they are  
at far lower risk of becoming 
infected than they would be 
today 
• If they do acquire HIV, they 
have access to treatment  
that helps prevent them from 
developing AIDS and passing  
the virus to others 
 
 




ACCELERATED PEPFAR GOALS 
The implications of scientific breakthroughs to contain the 
HIV/AIDS epidemic and the possibility of an AIDS-free 
generation prompted President Obama to announce 
accelerated goals for 2013 for each of the core interventions 
identified as drastically reducing the transmission of HIV (see 
below). This announcement has reinvigorated the world 
community in the fight against HIV/AIDS. 
 
 Photo: White House 
 
Progress toward Presidential 2013 Goals 
 























Note: PEPFAR totals include CDC contributions 
Source: PEPFAR World AIDS Day 2012 Update; CDC, 2012 
 
 
CDC: 370,000 women PEPFAR: 
750,000 women 
 
Presidential 2013 goal: 1.5 million women 
Presidential 2013 goal: 4.7 million circumcisions 
CDC: 832,500  
circumcisions 
PEPFAR: 2 million 
circumcisions 
 
PEPFAR: 5.1 million people 
Presidential 2013 goal: 6 million people 
CDC: 2.6 million people 
 










Although tremendous progress has been achieved, and we have the tools needed to create an AIDS-free 
generation, our work is not done. We need to reach many more people, improve public health 
infrastructure, and build country capacity to end this epidemic. This effort will require stretching every 

























“We stand at a tipping point in the fight against HIV/AIDS, and working 
together, we can realize our historic opportunity to bring that fight to 
an end.” - President Barack Obama, 2012 World AIDS Day
34 million people 
were living with HIV 
but only 50% knew 
their HIV status. 
Nearly 50% of the 14.8 
million people who were 
eligible for HIV treatment 
did not receive treatment. 
72% of eligible 
children living with HIV 




Only 30% of eligible 
















































Section 2:  
USING CDC’S SCIENTIFIC EXPERTISE  
TO FIGHT GLOBAL HIV/AIDS 
 










Leveraging Science to Win the Fight 
 
CDC has conducted HIV/AIDS research for over 30 years at home and abroad. Since the inception of PEPFAR in 2003, 
CDC has published over 700 articles in peer-reviewed publications covering a wide range of HIV research including  
multi-country studies to determine program impact as well as the most efficient and effective ways to implement 
HIV/AIDS programs.  
 
CDC also consistently and efficiently translates scientific findings into high impact strategies and programmatic 
interventions. Once piloted and put into practice, CDC works with PEPFAR-supported host countries to implement 
strategies and interventions throughout their national HIV programs. Examples are below. 
 




























Read article  
Mother-to-Child Transmission 
Read article  
Read article  
HIV Treatment Outcomes 
Male Circumcision 
 










Technical Expertise and Focus Areas 
 
CDC’s workforce of clinicians, health scientists, prevention specialists, epidemiologists, laboratorians, 
and public health advisors work side-by-side with Ministries of Health and other host country partners 
to implement effective national HIV programs in the core technical areas below.  
(For more information, go to www.cdc.gov/globalaids/) 
 
HIV Care and Treatment – Expanding services for quality HIV/AIDS care and treatment and 
transitioning these services to full host country leadership in under 10 years without compromising 
service quality 
 
TB-HIV Integration – Integrating TB and HIV services to reduce illness and death 
 
Maternal and Child Health – Expanding quality care and treatment services for women and 
children to address their unique needs and vulnerabilities 
 
HIV Prevention – Implementing a comprehensive, evidence-based prevention approach to halt  
new infections 
 
HIV Counseling and Testing – Scaling up a variety of proven approaches to testing and 
counseling, which serve as critical entry points for initiating prevention, care, and treatment services 
 
Local Workforce Capacity – Building workforce capacity to ensure that Ministries of Health 
and other local partners can lead and implement their own HIV response 
 
International Laboratories – Establishing high quality laboratory networks and systems to 
support the HIV response as well as manage other infectious and non-infectious diseases  
 
Disease Surveillance and Program Monitoring Systems – Strengthening disease 
surveillance and health systems for disease and program monitoring to ensure data-driven decision-
making and program impact 
 
Health Economics – Conducting groundbreaking research to identify and assess program costs, 
efficiency, and societal benefits 
 
Health Information Systems – Supporting the design and development of national health 
information systems that provide the infrastructure and information necessary for enhanced health  
care delivery and national planning
 










Synergies across the Agency 
 
CDC works strategically across the agency to harness its diverse technical expertise and create synergies 
for increased health impact and improved outcomes. For instance, CDC assesses strategies and tools 
proven to be effective in the United States and adapts them for use in resource-constrained settings. 
Examples below illustrate interventions developed by scientists from across CDC. 
 
Basic Care Package 
This integrated intervention reduces deaths, hospital visits, and illness among HIV-positive 
people and their families by bundling high impact, low-cost interventions that minimize 
susceptibility to common HIV-associated infections. The mix of interventions selected by 
experts across CDC are tailored to each setting and can include powerful antibiotics, 
insecticide-treated bed nets to prevent malaria, screening and management of sexually 
transmitted diseases, services to prevent mother-to-child transmission, and safe water 





CDC originally developed the Families Matter program for the U.S. 
HIV response to promote effective parent-child communication on 
sexual risk reduction for 9-12 year olds. With the support of those 
who created the program, CDC has been able to culturally adapt it 
for use in African settings. Successfully piloted in Kenya, CDC is now 
implementing the program in PEPFAR-supported countries 




CDC leverages its HIV and TB disease experts to advance 
efforts to integrate and scale-up effective TB-HIV service 
delivery. For example, CDC is collaborating with Ministries 
of Health on projects in Zambia and Namibia that evaluate 
the impact of national scale-up of intensified TB case 
finding, isoniazid preventive therapy, TB infection control, 
and early initiation of antiretroviral treatment (ART) on 


















































Using a Comprehensive, Evidence-Based Approach 
 
SCALING-UP WHAT WORKS 
CDC uses a comprehensive combination prevention strategy that is tailored to the unique characteristics of the local epidemic 
and leverages high impact biomedical interventions proven to work. These core interventions include HIV treatment to reduce 
transmission to partners, prevention of mother-to-child transmission, and voluntary medical male circumcision (VMMC). 
PEPFAR progress in scaling up these interventions is illustrated in figure 4. 
 












Sources: PEPFAR World AIDS Day 2012 Update; PEPFAR Annual Reports, 2011 and 2012; Joint PEPFAR-WHO VMMC Meeting, Johannesburg, S.A., September 2012 
 
 
DATA-DRIVEN DECISION MAKING 
CDC works with host countries to establish and use 
surveillance systems to determine how the epidemic  
is spreading through their populations. With this 
knowledge, rapid course corrections can be made  
to increase impact.  
 
Program monitoring systems are also established to 
track and evaluate program progress and effectiveness. 
These data are critical to program planning for 
improved outcomes and greater impact. 
  
 
Sed ut perspiciatis unde omnis iste natus error sit 
voluptatem accusantium doloremque laudantium, totam 
rem aperiam, eaque ipsa quae ab illo inventore veritatis et 
quasi architecto beatae vitae dicta sunt explicabo. Nemo 
enim ipsam voluptatem quia voluptas sit aspernatur aut 
odit aut fugit, sed quia consequuntur magni dolores eos 
qui ratione voluptatem sequi nesciunt. Neque porro 
quisquam est, qui dolorem ipsum quia dolor sit amet, 
consectetur, adipisci velit, sed quia non numquam eius 





Current number of people  




Annual number of HIV positive 
pregnant women receiving 
antiretroviral drugs  
 
Cumulative number of voluntary 
medical male circumcisions 
performed  
 
59% 25% 373% 
 










Accelerating Progress and Capacity 
 
INNOVATION AND TECHNOLOGY  
Advances in innovation and technology can rapidly accelerate progress, increase program capacity, and achieve efficiencies. 
CDC has developed new advances as well as leveraged existing US-based innovation and technology by adapting them for 
use in resource-constrained settings and replicating them throughout PEPFAR-supported countries. Below are examples  




Increased Prevention Impact: Dried Blood Spot Technology 
Left untreated, 50-60% of HIV-infected infants die by age two. Using highly stable, low-
cost dried blood spot technology, CDC introduced a game-changer for early infant 





New HIV Incidence Test 
CDC developed a simple, low 
cost test that can distinguish 
old from new infections.  
This information can then  
be used to identify where the 
highest rates of new infection 
are occurring so that prevention 
efforts can be aligned accordingly 
and assessed for effectiveness. Training for this 
technology is being conducted in China, Ghana, 
Kenya, Nigeria, South Africa, Swaziland, Thailand, 
Vietnam, Zambia, and Zimbabwe.  
(Photo: CDC-South Africa) 
 
Harnessing Technology to Improve 
Treatment Scale-Up 
Monitoring the scale-up of HIV treatment is 
challenging in resource-limited settings. To 
address this challenge, CDC supported the 
development of TRACnet, an innovative cell-
phone and web-based data management 
system that is quick and easy to use, even in 
the most remote health facilities. In Rwanda, 
this system captured essential data during the 
rapid scale-up of HIV treatment, which 
helped them achieve high levels of  
treatment coverage, including  
in hard-to-reach populations. 
 
 










Increasing Cost-Effectiveness and Impact 
 
STRETCHING EVERY DOLLAR INVESTED 
CDC’s groundbreaking work in cost-effective and efficient programming ensures the greatest impact for 
every dollar invested. This work included PEPFAR’s first multi-country expenditure analysis project to 
identify key cost drivers and estimate the annual per-patient costs of HIV services. Results of this are 




PEPFAR’s annual cost of 
supporting a patient on 
treatment has declined from 
approximately $1050 in 2004 
(when PEPFAR began) to under 








Source: PEPFAR Blueprint (2012) 
 
 
Expenditure Analysis Boosts Program Efficiencies and Impact 
CDC has led the way in developing tools for routine expenditure analysis that links costs to program 
outputs. These tools have become a cornerstone of PEPFAR’s plan to accelerate program efficiency and 

















Advancing Strategic Collaboration  
 
Through strategic partnerships, CDC is able to extend its reach and impact. A wide range of 
collaboration constructs are used including embedding CDC staff within partner-organizations such 
as Ministries of Health, WHO, World Bank, Department of State, OGAC, USAID, and DoD. 
Public-private partnerships have also played an important role in increasing PEPFAR impact.  An 
example of this is a successful collaboration with Becton, Dickinson and Company to improve 





CDC contributed to more 
than 95 WHO HIV/AIDS 
guidelines since 2003. 










CDC has worked to establish a number of innovative partnerships, all of which were designed to have a 
lasting and multi-sector impact such as the establishment of ARC, see below. CDC is also working to put 
in place self-sustaining collaborations such as the African Society for Laboratory Medicine (see p. 19).  
 
The African Health Profession Regional Collaborative (ARC) 
ARC is implemented in partnership with the Commonwealth 
Secretariat (based in the UK); the Commonwealth Nurse 
Federation; the Emory University School of Nursing; and the 
East, Central, and Southern Africa Health Community, which 
serves as an intergovernmental regional coordinating body. 
Through ARC, national nursing and midwifery leadership works together to improve professional 
regulation in the region. Through peer-to-peer collaboration and sharing of resources, ARC not 
only advances rapid scale-up of regulatory reform in the region, but also builds long-term capacity 














Strengthening Program Integration 
 
STRATEGIC PROGRAM INTEGRATION AND LINKAGES 
Strong program integration at both the program and service delivery levels will result in increased 
efficiency and improved health outcomes. CDC accomplishes this integration by tapping into existing 
health platforms that are complementary to each other. CDC further increases host country capacity by 
ensuring health infrastructure and systems are well integrated including disease surveillance, health 




Integrating HIV and Tuberculosis (TB) Service Delivery 
TB is the most common co-infection among people with HIV and 
the most common cause of death for people living with HIV in 
sub-Saharan Africa. CDC supports research and other efforts 
designed to improve health impact through the integration of TB 





Integrating Services to Prevent Mother-to-Child Transmission 
(PMTCT) with Maternal and Child Health Care (MCH) 
CDC works to leverage limited resources by integrating service delivery 
into established in-country health care platforms. Integration of PMTCT 
into mainstream MCH care is particularly beneficial as it removes access 
impediments, which helps accelerate scale-up of PMTCT services and 








































Photo: African Society for Laboratory Medicine Conference 2012 
 










Successes in Transitioning to Country Leadership 
 
MAKING STRATEGIC INVESTMENTS 
 
CDC uses cooperative agreements to boost country capacity by pairing PEPFAR funding with CDC technical support that is 
tailored to fit the specific needs of the host country and unique characteristics of the local epidemic.  
  
Over time, as local capacity grows, funding is gradually transitioned away from U.S. domestic and international partners to 
host country partners. This trend is now accelerating as investments in workforce development, infrastructure, and systems 
take hold, increasing the momentum toward local implementation. CDC now invests more resources in Ministries of 
Health and other local partners than in U.S. or international partners (see figure 6 below). 
 
Figure 6.  CDC Investments Build Country Capacity  (FY 2004 – FY 2012)
 
• Faith-Based Organizations 
• Foreign Governmental Entities (Not MoH) 
• Hospitals 
• Ministries of Health (MoH) 
• Non-Governmental Organizations 












• Faith-Based Organizations  
(International/U.S.-based) 
• Multilaterals (such as WHO) 
• Non-Governmental Organizations 
(International/U.S.-based) 





















2004 2005 2006 2007 2008 2009 2010 2011 2012
Local International
Local Partners include: 
 
International Partners Include: 
 
 





CDC’S PROVEN TRACK RECORD 
CDC has successfully transitioned key components of the HIV response to country 
leadership using a stepwise approach that builds host country capacity and independence 





All National Blood Safety Programs Transitioned 
 
If a person receives a blood transfusion 
with HIV-infected blood, there is a 95% 
risk they will become infected with HIV. 
In 2004, CDC began working with 
PEPFAR-supported countries to 
establish and strengthen national blood 
transfusion services. Since that time, all 
of these programs have been 
transitioned to Ministries of Health 






HIV Care and Treatment Services Transitioned 
 
CDC has been working with Ministries of 
Health and other country partners to 
transition care and treatment services to 
host country leadership and management. 
As of December 2012, approximately half 
of the 1,300 health facilities supported by 
CDC in sub-Saharan Africa have been 
successfully transitioned.  














Building Host Country Capacity 
 
LEVERAGING CDC’s UNIQUE WORKFORCE 
CDC’s workforce of clinicians, health scientists, prevention specialists, epidemiologists, laboratorians, 
and public health advisors are strategically located in PEPFAR-supported countries to work directly with 
Ministries of Health and other local partners to build institutional capacity.  
 
CDC’s decades-long relationships with Ministries of Health have inspired the trust and on-the-ground 
collaboration that supports the transfer of knowledge and skills that are essential to implement and 
sustain an effective HIV response. 
 


















• Currently, CDC staff are positioned in 45 country offices,  
with many embedded or co-located in Ministry of Health facilities.  
• Most of these staff are host country nationals who receive daily mentoring 
and on-the-job training.  
• Additionally, headquarters staff in Atlanta provide support  









STRENGTHENING LABORATORY CAPACITY 
A strong national laboratory system is essential for responding effectively to HIV and other 
diseases. Tremendous strides have been made in the establishment of high quality laboratory 
networks in partner countries. CDC’s approach to building laboratory capacity is to ensure 




National Laboratory Plans 
To promote country leadership, CDC 
works with Ministries of Health to support 
the development of national strategic plans 
for laboratories. These plans support all 
health sectors, build efficiencies, and enable 
countries to respond effectively to HIV and 





Self-Sustaining Laboratory Accreditation Program  
In 2008, CDC, in collaboration with WHO and 12 African governments, launched a 
laboratory accreditation program for sub-Saharan Africa that supports stepwise 
improvement toward accreditation. This program promotes measurable 
improvement in establishing high quality laboratories in resource-limited settings.  





African Society for Laboratory Medicine 
CDC was instrumental in establishing ASLM to 
strengthen laboratory networks across the African 
continent. ASLM is composed of and led by African Ministries of Health and 
laboratory leadership as well as other local, regional, and international leaders and 
partners. ASLM convened its first international conference in December 2012 with 
1,000 participants from 64 countries, and has launched the African Journal of 








High Impact Laboratory Training 
 
 
Regional Center of Excellence for Laboratory Training 
CDC led the establishment of the African Centre 
for Integrated Laboratory Training in 
Johannesburg, South Africa. This facility is the 
first of its kind and has trained hundreds of 
individuals from sub-Saharan Africa, Asia, and 







Innovative Training for HIV Rapid Testing 
CDC and WHO have jointly developed a comprehensive 
tool kit to quickly scale-up the ability of PEPFAR-supported 
countries to perform accurate, reliable HIV rapid testing. 
The tool kit includes 16 modules packaged with a training 
video/DVD, presentation slides, a trainer’s guide, 






Strengthening Laboratory Management toward  
Accreditation (SLMTA)  
Since its launch in 2009, SLMTA has been embraced as a grassroots movement to 
improve laboratory capacity in resource-limited settings.  This innovative, task-based 
training and mentoring program enables immediate, measurable improvement using 
existing laboratory resources.  The effectiveness and popularity of this approach has 
taken root in many countries, stimulating improvement across the entire health 


































Section 5:  
CDC’s PRIORITIES MOVING FORWARD 
 










Accountability and Impact 
 
A FRAMEWORK FOR ACCOUNTABILITY 
CDC has implemented a series of robust accountability, oversight, and quality management mechanisms to 
ensure optimal public health impact and stewardship of U.S. government funds. The framework is built upon 
fiscal oversight and program strategy, monitoring, and evaluation. Core components are described below.  
 
Assessments of Data and Service Quality 
Ensuring the quality of data and services is vital to PEPFAR’s continued success. These assessments include 
in-depth reviews of select sites to ensure quality service delivery and robust data quality for program 
reporting and expenditure analysis. They also serve as a capacity-building initiative to improve quality 
assurance activities led by national governments and implementing partners.  
 
Site Monitoring System  
CDC is systematizing its approach to site monitoring to ensure service delivery quality and demonstrate 
good stewardship using standardized site-monitoring criteria and data systems to streamline site-visit 
assessment, documentation, and reporting. This system allows analysis of service-delivery quality at the 
site level as well as within and across PEPFAR-supported countries. 
 
Country Monitoring and Accountability System 
CDC proactively launched the Country Monitoring and Accountability System (CMAS) in 2011 to identify 
any challenges resulting from the rapid scale-up of complex CDC programs funded by PEPFAR. CMAS is 
designed to assess CDC’s fiscal and programmatic accountability in the following key areas: 
 
• Intramural Resources: Ensuring proper management and stewardship of financial resources, 
property, and human resources in CDC’s overseas offices 
 
• Extramural Funding: Ensuring responsible and accurate management of financial and other 
resources external to CDC’s overseas offices 
 
• Public Health Impact: Ensuring the delivery of consistently high quality interventions and technical 














All CDC country offices were visited and assessed 
between February 2011 and March 2012. Country 
offices now receive visits every two years. These visits 
will provide the same internal programmatic and financial 
oversight and will have an increased emphasis on the 
provision of supportive technical assistance to ensure 
continual improvement in HIV/AIDS program 
management and implementation.  
 






CDC carefully tracks program progress and impact using quantitative performance measures to ensure 
achievement of PEPFAR goals. These measures also help CDC gauge program maturity and effectiveness  
in key programmatic areas essential to mounting an effective HIV response. Each technical area and  
performance category tracked is provided below.  
 
  
HIV Prevention, Care, and Treatment 
• Antiretroviral treatment 
• Prevention of mother-to-child transmission 
• Voluntary medical male circumcision 
• TB screening and treatment 
• HIV testing and counseling 
• Reaching key populations 
• Early infant HIV testing 
• Provision of care 
 
Health Systems Strengthening 
• Workforce capacity 
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REACHING THE TIPPING POINT IN THE EPIDEMIC 
 
The 2012 PEPFAR Blueprint introduced a “tipping point” metric to determine if countries are 
on a sustainable scale-up path for containing the spread of HIV. This tipping point occurs when 
the annual increase in patients on treatment exceeds annual new HIV infections. Achieving this 
point is a key step toward program sustainability, declining HIV prevalence, and eventual 











PEPFAR-supported countries are progressing at different rates toward their epidemic  
tipping points. Eleven countries have reached the tipping point (represented by the dark  
green bars in the figure below) and four more are close to achieving it (light green bars). 
 
HIV/AIDS Programmatic Tipping Point in 2011 



















The battle against HIV/AIDS is yielding to  
















• Decline in HIV Prevalence 
• Pre-AIDS Life Expectancy 
and Productivity 
• Societal Cost Savings 
 
Annual Increase  




















HISTORY IN THE MAKING 
The United States is leading the way toward ending the HIV/AIDS epidemic. What was thought to be 
impossible is being achieved. Millions of lives are being saved every day and the capacity for PEPFAR-
supported countries to lead, implement, and finance their HIV response is growing. 
 
 
  PEPFAR IMPACT (FY 2012 unless otherwise noted) 
 
• Life-saving antiretroviral drug treatment for nearly 5.1 million people,   
up from 1.7 million in 2008 (as of September 2012) 
• HIV testing and counseling for more than 11 million pregnant women 
• Antiretroviral drug prophylaxis to prevent mother-to-child HIV transmission  
for nearly 750,000 HIV-positive pregnant women, allowing approximately 
230,000 infants to be born HIV-free 
• Care and support for nearly 15 million people, including more than  
4.5 million orphans and vulnerable children 
• HIV counseling and testing for more than 46.5 million people,  
providing a critical entry point to prevention, treatment, and care 
• Medical circumcision procedures for approximately 2 million men  
(cumulative through September 2012) 
 




“There is great reason for hope, but the job is far from finished … the opportunity before us  
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Download this Program Update at 
www.CDC.gov/globalaids/publications/CDC-Global-HIV-Update-2013.pdf 
For more information on the Division of Global HIV/AIDS, visit www.CDC.gov/globalaids 
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